Literature DB >> 26846364

Lower Serum Zinc and Higher CRP Strongly Predict Prenatal Depression and Physio-somatic Symptoms, Which All Together Predict Postnatal Depressive Symptoms.

Chutima Roomruangwong1, Buranee Kanchanatawan1, Sunee Sirivichayakul2, Boris Mahieu3, Gabriel Nowak4,5, Michael Maes6,7,8,9,10.   

Abstract

Pregnancy and delivery are associated with activation of immune-inflammatory pathways which may prime parturients to develop postnatal depression. There are, however, few data on the associations between immune-inflammatory pathways and prenatal depression and physio-somatic symptoms. This study examined the associations between serum zinc, C-reactive protein (CRP), and haptoglobin at the end of term and prenatal physio-somatic symptoms (fatigue, back pain, muscle pain, dyspepsia, obstipation) and prenatal and postnatal depressive and anxiety symptoms as measured using the Edinburgh Postnatal Depression Scale (EPDS), Beck Depression Inventory (BDI), Hamilton Depression Rating Scale (HAMD), and Spielberger's State Anxiety Inventory (STAI). Zinc and haptoglobin were significantly lower and CRP increased at the end of term as compared with non-pregnant women. Prenatal depression was predicted by lower zinc and lifetime history of depression, anxiety, and premenstrual tension syndrome (PMS). The latter histories were also significantly and inversely related to lower zinc. The severity of prenatal EDPS, HAMD, BDI, STAI, and physio-somatic symptoms was predicted by fatigue in the first and second trimesters, a positive life history of depression, anxiety, and PMS, and lower zinc and higher CRP. Postnatal depressive symptoms are predicted by prenatal depression, physio-somatic symptoms, zinc and CRP. Prenatal depressive and physio-somatic symptoms have an immune-inflammatory pathophysiology, while postnatal depressive symptoms are highly predicted by prenatal immune activation, prenatal depression, and a lifetime history of depression and PMS. Previous episodes of depression, anxiety disorders, and PMS may prime pregnant females to develop prenatal and postnatal depressive symptoms via activated immune pathways.

Entities:  

Keywords:  Chronic fatigue; Cytokines; Immune; Inflammation; PMS; Postnatal; Prenatal

Mesh:

Substances:

Year:  2016        PMID: 26846364     DOI: 10.1007/s12035-016-9741-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  84 in total

Review 1.  A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.

Authors:  Michael Maes; Piotr Galecki; Yong Seun Chang; Michael Berk
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-05-12       Impact factor: 5.067

Review 2.  Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action.

Authors:  Gabriel Nowak
Journal:  Pharmacol Rep       Date:  2015-02-08       Impact factor: 3.024

Review 3.  Metal ions and synaptic transmission: think zinc.

Authors:  E P Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

4.  Zinc in depression: a meta-analysis.

Authors:  Walter Swardfager; Nathan Herrmann; Graham Mazereeuw; Kyle Goldberger; Tetsuhiro Harimoto; Krista L Lanctôt
Journal:  Biol Psychiatry       Date:  2013-06-24       Impact factor: 13.382

5.  Predictive clinical and laboratory parameters for serum zinc and copper in rheumatoid arthritis.

Authors:  H Mussalo-Rauhamaa; Y T Konttinen; J Lehto; V Honkanen
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

6.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

7.  Immune activation in the early puerperium is related to postpartum anxiety and depressive symptoms.

Authors:  M Maes; A H Lin; W Ombelet; K Stevens; G Kenis; R De Jongh; J Cox; E Bosmans
Journal:  Psychoneuroendocrinology       Date:  2000-02       Impact factor: 4.905

8.  Pathways linking depression, adiposity, and inflammatory markers in healthy young adults.

Authors:  Gregory E Miller; Kenneth E Freedland; Robert M Carney; Cinnamon A Stetler; William A Banks
Journal:  Brain Behav Immun       Date:  2003-08       Impact factor: 7.217

Review 9.  Evidence for an immune response in major depression: a review and hypothesis.

Authors:  M Maes
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1995-01       Impact factor: 5.067

10.  Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

Authors:  M Maes; E Bosmans; R De Jongh; G Kenis; E Vandoolaeghe; H Neels
Journal:  Cytokine       Date:  1997-11       Impact factor: 3.861

View more
  8 in total

1.  [Inflammatory Biomarkers and Postpartum Depression: A Systematic Review of Literature].

Authors:  Mathilde Lambert; Florence Gressier
Journal:  Can J Psychiatry       Date:  2019-02-26       Impact factor: 4.356

2.  The Possible Effects of Zinc Supplementation on Postpartum Depression and Anemia.

Authors:  Chieko Aoki; Kenji Imai; Taro Owaki; Tomoko Kobayashi-Nakano; Takafumi Ushida; Yukako Iitani; Noriyuki Nakamura; Hiroaki Kajiyama; Tomomi Kotani
Journal:  Medicina (Kaunas)       Date:  2022-05-29       Impact factor: 2.948

3.  IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.

Authors:  Chutima Roomruangwong; Buranee Kanchanatawan; Sunee Sirivichayakul; George Anderson; André F Carvalho; Sebastien Duleu; Michel Geffard; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-04-01       Impact factor: 5.590

4.  How Depressive Symptoms among African American Women Relate to Measures of Social Disorder in Her Childhood and Pregnancy Neighborhood.

Authors:  Alexandra L Nowak; Carmen Giurgescu; Thomas N Templin; Rhonda K Dailey; Dawn P Misra
Journal:  J Urban Health       Date:  2020-02       Impact factor: 3.671

Review 5.  Precision medicine in perinatal depression in light of the human microbiome.

Authors:  Beatriz Peñalver Bernabé; Pauline M Maki; Shannon M Dowty; Mariana Salas; Lauren Cralle; Zainab Shah; Jack A Gilbert
Journal:  Psychopharmacology (Berl)       Date:  2020-02-17       Impact factor: 4.530

Review 6.  Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.

Authors:  Paula Kopschina Feltes; Janine Doorduin; Hans C Klein; Luis Eduardo Juárez-Orozco; Rudi Ajo Dierckx; Cristina M Moriguchi-Jeckel; Erik Fj de Vries
Journal:  J Psychopharmacol       Date:  2017-06-27       Impact factor: 4.153

Review 7.  Metabolomic Biomarkers in Anxiety Disorders.

Authors:  Elke Humer; Christoph Pieh; Thomas Probst
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

8.  The serum zinc concentration as a potential biological marker in patients with major depressive disorder.

Authors:  Krzysztof Styczeń; Magdalena Sowa-Kućma; Marcin Siwek; Dominika Dudek; Witold Reczyński; Bernadeta Szewczyk; Paulina Misztak; Roman Topór-Mądry; Włodzimierz Opoka; Gabriel Nowak
Journal:  Metab Brain Dis       Date:  2016-08-08       Impact factor: 3.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.